Company logo

NSTG - NanoString Technologies, Inc.

NASDAQ -> Healthcare -> Medical Instruments & Supplies
Seattle, United States
Type: Equity

NSTG price evolution
NSTG
(in millions $) 30 Sep 2023 30 Jun 2023 31 Mar 2023 31 Jan 2023
Current assets
Cash $94.1 $114.93 $122.03 $113.15
Short term investments $3.3 $3.3 $33.24 $84.28
Net receivables $48.35 $42.98 $34.87 $31.51
Inventory $55.16 $48.85 $46.71 $43.27
Total current assets $211.81 $221.44 $251.86 $286.77
Long term investments
Property, plant & equipment $59.41 $63.4 $64.21 $62.04
Goodwill & intangible assets
Total noncurrent assets $62.91 $67.55 $68.56 $66.64
Total investments $3.3 $3.3 $33.24 $84.28
Total assets $274.71 $288.99 $320.42 $353.41
Current liabilities
Accounts payable $33.34 $20.87 $20.49 $16.62
Deferred revenue $18.47 $17.12 $16.25 $13.34
Short long term debt $5.58 $5.44 $5.33 $5.52
Total current liabilities $77.53 $62.43 $57.99 $58.86
Long term debt $242.12 $243.18 $244.2 $226.62
Total noncurrent liabilities $247.75 $248.02 $248.8 $248.74
Total debt $247.7 $248.62 $249.54 $250.5
Total liabilities $325.28 $310.45 $306.8 $307.6
Shareholders' equity
Retained earnings -$931.61 -$894.2 -$850.53 -$809.3
Other shareholder equity $0 $0 -$0.06 -$0.59
Total shareholder equity -$50.57 -$21.46 $13.62 $45.81
(in millions $) 31 Jan 2023 31 Dec 2021 31 Dec 2020 31 Dec 2019
Current assets
Cash $113.15 $107.07 $411.85 $29.03
Short term investments $84.28 $241.82 $28.88 $127.82
Net receivables $31.51 $40.13 $31.1 $27.15
Inventory $43.27 $31.49 $22.96 $19.78
Total current assets $286.77 $427.62 $498.98 $212.61
Long term investments
Property, plant & equipment $62.04 $46.27 $42.32 $44.83
Goodwill & intangible assets
Total noncurrent assets $66.64 $51.86 $45.22 $47.15
Total investments $84.28 $241.82 $28.88 $127.82
Total assets $353.41 $479.48 $544.2 $259.75
Current liabilities
Accounts payable $16.62 $14.28 $5.31 $10.28
Deferred revenue $13.34 $11 $7.45 $4.97
Short long term debt $5.52 $4.89 $4.31 $3.77
Total current liabilities $58.86 $52.16 $37.1 $44.99
Long term debt $226.62 $246.84 $198.31 $109.32
Total noncurrent liabilities $248.74 $250.36 $200.15 $110.62
Total debt $250.5 $251.73 $202.62 $113.08
Total liabilities $307.6 $302.52 $237.25 $155.6
Shareholders' equity
Retained earnings -$809.3 -$649.75 -$542.03 -$431.95
Other shareholder equity -$0.59 -$0.32 $0.08 $0.14
Total shareholder equity $45.81 $176.96 $306.95 $104.15
(in millions $) 30 Sep 2023 30 Jun 2023 31 Mar 2023 31 Dec 2022
Revenue
Total revenue $48.09 $44.16 $35.8 $34.42
Cost of revenue $30.69 $29.76 $22.87 $21.12
Gross Profit $17.4 $14.4 $12.93 $13.3
Operating activities
Research & development $17.11 $18.21 $16.12 $19.09
Selling, general & administrative $36.76 $39.08 $37.37 $36.9
Total operating expenses $53.87 $57.29 $53.48 $55.98
Operating income -$36.47 -$42.89 -$40.55 -$42.68
Income from continuing operations
EBIT -$35.56 -$41.57 -$39.27 -$42.23
Income tax expense -$0.05 $0.2 $0.07 -$0.01
Interest expense $1.9 $1.89 $1.89 $1.89
Net income
Net income -$37.41 -$43.67 -$41.24 -$44.11
Income (for common shares) -$37.41 -$43.67 -$41.24 -$44.11
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Revenue
Total revenue $127.26 $145.09 $117.32 $125.57
Cost of revenue $65.47 $68.3 $52.41 $44.04
Gross Profit $61.79 $76.78 $64.91 $81.53
Operating activities
Research & development $70.84 $69.5 $62.86 $68.03
Selling, general & administrative $143.13 $115.5 $90.1 $96.19
Total operating expenses $213.97 $185.01 $152.95 $164.23
Operating income -$152.18 -$108.23 -$88.05 -$82.7
Income from continuing operations
EBIT -$151.69 -$107.6 -$94.42 -$31.94
Income tax expense $0.32 $0.17 $0.25 $0.27
Interest expense $7.54 $7.49 $15.41 $8.49
Net income
Net income -$159.54 -$115.25 -$110.08 -$40.7
Income (for common shares) -$159.54 -$115.25 -$110.08 -$40.7
(in millions $) 30 Sep 2023 30 Jun 2023 31 Mar 2023 31 Dec 2022
Net income -$37.41 -$43.67 -$41.24 -$44.11
Operating activities
Depreciation $5.07 $5.01 $4.64 $4.04
Business acquisitions & disposals
Stock-based compensation $7.44 $8.44 $7.63 $6.26
Total cash flows from operations -$19.7 -$31.45 -$35.75 -$28.08
Investing activities
Capital expenditures -$1.92 -$5.69 -$7.68 -$5.48
Investments $30 $51.48 $29.59
Total cash flows from investing -$1.92 $24.31 $43.8 $24.11
Financing activities
Dividends paid
Sale and purchase of stock $0.87 $0.09 $1.37 $0.02
Net borrowings -$0.04 -$0.06 -$0.07 -$0.08
Total cash flows from financing $0.82 $0.04 $0.81 -$0.05
Effect of exchange rate -$0.04 $0 $0.02 $0.1
Change in cash and equivalents -$20.83 -$7.1 $8.88 -$3.92
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Net income -$159.54 -$115.25 -$110.08 -$40.7
Operating activities
Depreciation $12.21 $9.32 $8.98 $7.75
Business acquisitions & disposals $40
Stock-based compensation $25.91 $30.17 $19.37 $17.46
Total cash flows from operations -$128.61 -$90.55 -$81.66 -$89.42
Investing activities
Capital expenditures -$23.07 -$8.65 -$7.46 -$7.88
Investments $155.56 -$211.57 $98.7 -$47.27
Total cash flows from investing $132.5 -$220.22 $91.24 -$15.16
Financing activities
Dividends paid
Sale and purchase of stock $4.11 $8.88 $237.44 $90.84
Net borrowings -$0.33 -$0.24 $145.02 $20
Total cash flows from financing $2.27 $6.06 $373.05 $109.27
Effect of exchange rate -$0.08 -$0.07 $0.19 -$0.01
Change in cash and equivalents $6.08 -$304.78 $382.63 $4.69
Fundamentals
Market cap $3.85M
Enterprise value $157.45M
Shares outstanding 48.11M
Revenue $162.47M
EBITDA -$139.88M
EBIT -$158.64M
Net Income -$166.43M
Revenue Q/Q 62.79%
Revenue Y/Y 20.09%
P/E ratio -0.02
EV/Sales 0.97
EV/EBITDA -1.13
EV/EBIT -0.99
P/S ratio 0.02
P/B ratio -0.08
Book/Share -1.05
Cash/Share 1.96
EPS -$3.46
ROA -53.79%
ROE 5.29K%
Debt/Equity 6.71
Net debt/EBITDA -1.65
Current ratio 2.73
Quick ratio 2.02